Sunday 18 October 2026 Export TNXP’s income statement to Excel — free account

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp.’s revenue for fiscal 2025 (year ended December 2025) was $13.1 million, up 29.8% from fiscal 2024. In the quarter to June 2026, revenue grew 577.9%, EPS grew 36.8% and free cash flow fell 178.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

6.04 0.38 −5.92%

Follow TNXP

Alert me

Market cap: $110.1M
P/E: 0.0×
Fwd P/E: −1.0×
Dividend yield: —
F-score: 5/9
Altman Z: −2.42
Beneish M: −2.38
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		20.93	10.14	10.74	7.29
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(7.49)	(3.35)	(4.45)	(5.02)
P/B ratio Full definition →		0.93	0.54	0.83	0.95
Price to Tangible BV Full definition →		0.93	0.54	0.83	0.96
EV/Sales Full definition →		3.20	(5.13)	0.60	1.50
EV/EBITDA Full definition →		0.00	0.54	0.00	0.00
EV/Operating CF Full definition →		(0.44)	0.67	(0.08)	(0.28)
EV/FCF Full definition →		(0.43)	0.65	(0.08)	(0.28)
Quick Ratio Full definition →		9.20	6.94	6.55	6.11
Current Ratio Full definition →		9.89	7.42	6.99	6.61
Net Debt/EBITDA Full definition →		5.83	4.34	4.53	4.20
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.06	0.06	0.08	0.13
Operating CF/Net income Full definition →		0.90	0.85	1.05	1.04
Capex/Depreciation Full definition →		(2.09)	(3.84)	(3.05)	(0.95)
Research and Development Expense of Revenue Full definition →		282.34%	314.30%	264.80%	143.36%
Selling, General and Administrative Expense of Revenue Full definition →		781.19%	661.91%	416.17%	265.50%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		58.45%	33.19%	28.64%	16.66%
Graham Net Nets Full definition →		0.87	1.48	0.94	0.81
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(83.03%)	(93.32%)	(106.66%)	(103.81%)
Free Cash Flow Yield Full definition →		(35.40%)	(77.63%)	(69.31%)	(74.49%)
Revenue per Share Full definition →		0.37	0.63	0.50	0.81
Operating CF per Share Full definition →		(3.23)	(4.66)	(3.09)	(2.54)
Capex per Share Full definition →		(0.11)	(0.22)	(0.12)	(0.04)
Free Cash Flow per Share Full definition →		(3.33)	(4.88)	(3.21)	(2.57)
Cash per Share Full definition →		21.30	24.40	13.53	10.59
Shareholders Equity per Share Full definition →		25.90	28.80	16.57	13.36
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		25.90	28.80	16.57	13.36
Free Cash Flow Full definition →		(29.74)	(41.52)	(44.01)	(42.83)
Working Capital Full definition →		187.04	198.04	177.52	172.65
Capital Expenditures Full definition →		(0.96)	(1.87)	(1.69)	(0.59)
Net Current Asset Value Full definition →		186.77	196.86	176.39	171.63
EV/EBIT Full definition →		0.00	0.53	0.00	0.00
Capex to Sales Full definition →		0.29	0.35	0.25	0.04
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		3.75	4.98	6.07	7.06
Average Payables Full definition →		6.24	6.33	6.92	8.42
Average Inventory Full definition →		6.83	7.21	5.89	5.33
Average Assets Full definition →		173.71	220.03	225.39	220.72
Average Common Equity Full definition →		152.68	192.35	203.77	195.14

Show all line items

Columns are period end dates

Stockrow Weekly